GC Pharma Receives Korea's MFDS Approval of GCFLU Quadrivalent (Influenza Vaccine) for persons 6 months and older

YONGIN, South Korea, Sept. 30, 2018 /PRNewswire/ — GC Pharma (formerly known as Green Cross) announced today it has received approval from the South Korean Ministry of Food and Drug Safety (MFDS) expanding the indication for GCFLU Quadrivalent™ (Seasonal Influenza Vaccine) to include use in persons 6 months and older. Prior to this, the vaccine was approved for use in persons 3 years of age and older.

GCFLU Quadrivalent

Read the full article by GC Pharma

Share on facebook
Share on twitter
Share on linkedin
Back to Top